Get Started
Speak to us and get started with your QP today

Contact
Search

Q and A from the EMA on Biosimilars

See this post from the EMA:
Just published: Q&A on the interoperability of biosimilar medicines in the European Union.

This Q&A responds to questions raised by the publication of a statement on biosimilar interchangeability by EMA and the Heads of Medicines Agency last September.

Read the Q&A and find out more about biosimilar medicines: https://lnkd.in/ehmCgcEP

Ryoma Collia

Let us tell you more

We will email you to start the conversation

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.